SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235 | +147.4% | 67,754 | +229.1% | 0.02% | +122.2% |
| Q1 2023 | $95 | -73.3% | 20,588 | -53.2% | 0.01% | -79.5% |
| Q4 2022 | $356 | -100.0% | 44,032 | -73.4% | 0.04% | -63.9% |
| Q3 2022 | $919,000 | -19.1% | 165,544 | -24.1% | 0.12% | -28.2% |
| Q2 2022 | $1,136,000 | +290.4% | 218,115 | +515.4% | 0.17% | +335.9% |
| Q1 2022 | $291,000 | -72.6% | 35,442 | -50.4% | 0.04% | -70.9% |
| Q4 2021 | $1,063,000 | – | 71,412 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |